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ABSTRACT
Phosphorylation of target proteins by protein kinases leads to the activation of cellular signaling pathways, which induce a
great number of biological processes including cell growth, differentiation, development, and death. Although the activities of
protein kinases are stringently regulated in homeostasis system, protein kinases can be deregulated under pathological conditions,
leading to perturbation of protein kinase-mediated cell signaling pathways and resulting in various disorders including cancer,
diabetes, and inflammation. The data from the Human Genome Project has revealed that 518 protein kinases are encoded in the
human genome, thereby creating an enormous repertoire of potential targets for chemoprevention. Polyphenols, as integral
constituents of the diet, have been proposed to exert beneficial effects in a multitude of disease states. Recent studies have
suggested that the cellular effects of polyphenols are, at least partly, mediated by their interactions with protein kinases central to
intracellular signaling cascades. In the present study, we investigated the interaction of polyphenols-protein kinases by pull down
assay, affinity assay and computer simulation. The results revealed that some polyphenolic compounds suppressed the
phosphorylation of various protein kinases with different affinity and selectivity. Finally, we discussed the impact of these
polyphenols-protein kinases interactions on cellular signaling and chemoprevention.
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INTRODUCTION
Protein kinase is a type of enzyme that transfers
phosphate groups from high-energy donor molecules such
as adenosine triphosphate (ATP) to specific substrates.
This process is referred to as phosphorylation. According
to the catalytic specificity, protein kinases can be subdivided into three categories: Tyrosine (Tyr) kinase, Serine/Threonine (Ser/Thr) kinase, and kinase specific for
both Tyr and Ser/Thr. Phosphorylation of these sites in
target proteins leads to the activation of signal transduction pathways, which play important roles in a great
number of biological processes including cell growth,
differentiation, development, and death. The activities of
protein kinases are stringently regulated in homeostasis
system. However, protein kinases can be deregulated under pathological conditions, leading to perturbation of
protein kinase-mediated cell signaling pathways and resulting in various disorders including cancer, diabetes,
and inflammation(1). The data from the Human Genome
Project has revealed that 518 protein kinases are encoded
in the human genome, and each cell will have approximate ~50 - 100 protein kinases(2) , thereby creating an
enormous repertoire of potential targets for drug discovery(3). Alterations in multiple cellular signaling pathways

are frequently found in many cancer cells. It may be the
reason why the specific inhibitors that target only one
pathway, most often, failed in cancer treatment(4). Thus,
compounds that can suppress multiple cellular signaling
pathways would have great potential in chemoprevention.
Polyphenolic compounds may be good sources for
this since some of them appear to address multiple targets.
Polyphenols, as integral constituents of the diet, are one
of the biggest families of natural products and have been
proposed to exert beneficial effects in a multitude of disease states, including cancer, cardiovascular disease, and
neurodegenerative disorders. Classically, many of the
biological actions of polyphenols have been attributed to
their antioxidant properties, either through their reducing
capacities or through their possible influences on intracellular redox status. However, recent studies have speculated that their classical hydrogen-donating antioxidant
activity is unlikely to be the sole explanation for cellular
effects. Recent studies from our group and other groups
have suggested that the cellular effects of polyphenols
may be mediated by their interactions with specific proteins central to intracellular signaling cascades(5). In particular, investigations have indicated that polyphenols
may interact selectively at different components of a
number of protein kinase signaling cascades such as
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phosphoinositide 3-kinase (PI3K), Akt/protein kinase B
(Akt/PKB), protein kinase C (PKC), and mitogen-activated protein kinase (MAPKs)(6-8). Some polyphenols can directly bind these protein kinases and alter
their phosphorylation state to regulate multiple cell signaling pathways, and finally affect various cellular functions such as cell defense, neuroprotective, cardioprotective, and cancer chemopreventive actions.
In this study, author reports the results in the
interaction of protein kinases-polyphenols, special in the
direct binding and molecular modeling of protein
kinases-polyphenols. Moreover, the binding sites,
selectivity, and the impact on cellular signaling and
chemoprevention
of
polyphenol-protein
kinase
interactions are discussed.

MATERIALS AND METHODS
I. Pull Down Assay
Myricetin-Sepharose 4B beads were prepared as described previously(9). Briefly, polyphenols (3 mg) was
coupled to cyanogen bromide (CNBr)-activated Sepharose 4B beads (25 mg) in a coupling buffer(17) overnight
at 4C according to the manufacturer’s instructions. The
mixture was washed in 5 volume of coupling buffer and
then centrifuged at 1,000 rpm for 3 min at 4C. The precipitate was resuspended in 5 volume of 0.1 M Tris-HCl
buffer (pH 8.0) with 2 h rotation at room temperature
(RT). After washing three times with 0.1 M acetate buffer
(pH 4.0) containing 0.5 M NaCl, the mixture was further
washed with 0.1 M Tris-HCl (pH 8.0) buffer containing
0.5 M NaCl. The cell lysates (500g for ex vivo assay) or
recombinant active protein kinase (100 ng for in vitro
assay) were incubated at 4C overnight with Sepharose
4B beads or Sepharose 4B-polyphenol-coupled beads
(100 L, 50% slurry) in a reaction buffer(17). The beads
were then washed 5 times with a washing buffer(17). The
proteins were applied to SDS-PAGE and then detected by
immunoblotting.
II. Affinity Analysis of Polyphenol-Protein Kinase
Interaction
Affinity of polyphenol to protein kinase was
measured by Quartz-crystal microbalance (QCM)(9).
Recombinant protein kinase (100 ng) was immobilized
into a QCM electrode plate for 1 h at RT. After washing 5
times with a binding buffer(11), the electrode plate was
immersed in the analysis chamber with binding buffer at
25C. Polyphenol was injected stepwise into the analysis
chamber (0.1 - 12.6 M). The binding affinity was
indicated by frequency changes of QCM, and
disassociation constant (Kd) was calculated by AFFINIX
Q User Software (AQUA; Initium).
III. Western Blotting
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Immunoblotting was performed as described previously(9). The cells were lysed in a modified RIPA buffer.
The lysed cells were homogenized in an ultrasonicator for
15 s twice on ice and then centrifuged at 14,000 g for 15
min at 4C. The protein concentration of the supernatant
was determined using dye-binding protein assay kit
(Bio-Rad) according to the manufacturer’s manual. Approximate 10 - 30 g proteins were run on SDS-PAGE
and then transferred to PVDF membrane (Amersham
Biosciences). The blotted membrane was incubated with
a specific primary antibody for 2 h at RT, and then incubated for 1 h with HRP-conjugated secondary antibody.
Bound antibodies were detected by Immobilon Western
System (MILLIPORE), and further quantified by Lumi
Vision Imager software (TAITEC Co.).
IV. Molecular Modeling of Polyphenol-Protein Kinase
Docking
Computer modeling of polyphenolic compound to
protein kinase was performed using Molecular Operating
EnvironmentTM software (MOE, Version 2008.10, Chemical Computing Group Inc.). The 3D structure of protein
kinase was obtained from Protein Data Base (PDB,
http://www.rcsb.org/pdb/) and crystallization water and
other molecules involved in protein kinase structure were
deleted. Hydrogen atoms were first added, and forcefield
(MMFF94x) atomic charges were assigned. Docking of
myricetin to Akt1 was done using MOE- ASEDock 2005
software(10).

RESULTS AND DISCUSSION
I. A Polyphenolic Compound Can Target Multiple Protein Kinases
We chose myricetin, a typical polyphenol existing in
many fruits and vegetables, to investigate the direct targets of protein kinase. Binding assay revealed that myricetin bound to Akt directly by competing with ATP. Molecular modeling further suggested that myricetin easily
docks to the ATP-binding site of Akt with hydrogen
bonds. On the other hand, myricetin also could directly
bind to JAK1/STAT3 molecules. Affinity data further
demonstrated that myricetin had a higher affinity for
JAK1 than STAT3. Other groups reported that myricetin
further bound to MEK1(11), PI3K(12), Fyn(13), and MKK4
(14)
. These data shown that one polyphenol can target several protein kinases. The number and substitution of hydroxyl groups on the B-ring and the degree of unsaturation of the C2 - C3 bond of polyphenol appear important
determinants of this particular bioactivity(15). The potential of polyphenol binding to protein kinases will depend
on both the structure of polyphenol (e.g. the number and
position of hydroxyl group on the B-ring, and the degree
of unsaturation of the C2 - C3 bond of flavonoids) and the
properties of different protein kinase (e.g. selectivity of
ATP-pocket, the architecture in the adjacent to the
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ATP-binding site).

Figure 1. Myricetin directly binds to Akt, MEK1, JAK1 and STAT3,
but not EGFR. Whole cell lysate was precipitated with Sepharose
4B beads or Sepharose 4B-myricetin-coupled beads as described in
Materials and methods. Whole cell lysate (input control, lane 1),
precipitate with Sepharose 4B beads (negative control, lane 2) or
Sepharose 4B-myricetin-coupled beads were applied to SDS-PAGE,
and detected with their antibodies, respectively, after transferring to
membrane.

Figure 2. Myricetin binds the ATP-pocket of multiple protein
kinases. The chemical structure of myricetin is showing in the
(12)
middle. (A) PI3K (PDB ID : 2DQ7)
. (B) MKK4 (PDB ID :
(14)
(10)
2DYL)
. (C) Akt (PDB ID : 3CQW)
. (D) Fyn (PDB ID :
(13)
2DQ7)
. Hydrogen bonds between myricetin and protein kinase
are indicated by arrows.

II. A Protein Kinase Can be Targeted by a Variety of
Polyphenolic Compounds
MEK1/2 is a critical kinase in MAPK signaling
pathway. It is found that this protein kinase, at least, can
be directly bound with delphinidin, quercetin, and equol.
As shown in Figure 3C, Equol, a metabolite of daidzein,
is docked to a pocket separate from but adjacent to the
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ATP-binding site similar to PD318088 (ATP
noncompetitive inhibitor of MEK1) as observed in the
crystal structure of the MEK1-PD318088 complex l(16)
(Figure 3A). The hydroxyl group at the 7 position of
equol can make a hydrogen bond with the backbone
carbonyl group of Val127 in the ATP noncompetitive
binding site.
Quercetin(17) is also reported to dock to the pocket
separate from but adjacent to the ATP-binding site of
MEK1 (Figure 3B). The hydroxyl group at the 7 position
can make a hydrogen bond with the backbone carbonyl
group of Val127 in the ATP noncompetitive binding site.
The C-ring interacts with the residues in the activation
loop of the inactive MEK1. Val211 and Leu215 form van
der Waals interactions with the C-ring of quercetin. The
hydroxyl group at the 3' position of the C-ring can make a
critical hydrogen bond with the backbone amide group of
Ser212. These interactions of quercetin with the
activation loop would lock MEK1 into a catalytically
inactive species by stabilizing the inactive conformation
of the activation loop.
Delphinidin, a typical aglycone of anthocyanins, is
reported to dock to the pocket separate from but adjacent
to the ATP-binding site of MEK1(18). The interactions by
the C-ring moiety are critical for the holding of the
activation loop of the inactive MEK1 (Figure 3C).

(16)

(17)

Figure 3. Molecular modeling of equol (A)
, quercetin (B) ,
(18)
and delphinidin (C)
binding to MEK1. (Top) The tube model of
MEK1 structure (PDB ID : 1S9J)).

III. Selectivity vs. Multiple Targets
Most diseases involve multiple molecular abnormalities with more than one dysfunctional proteins although a highly selective drug can target a single molecule responsible for the etiology of a disease. Therefore,
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drugs whose efficacy is based on rebalancing the several
proteins that contribute to the pathogenesis and progression of a disease may be ideal(4).
The lack of selectivity of protein kinase inhibitor can
sometimes be advantageous since anticancer drugs that
act on multiple tyrosine kinases are thought to be more
effective than those that are specific in their mode of action(19). Flavonoids that can suppress these multiple
pathways would have great potential in cancer chemoprevention and cancer treatment. On the other hand,
cross-reactivity with unrelated ATP-binding proteins is
also a frequent problem, resulting in undesirable side effects that cause many protein kinase inhibitors to fail in
either preclinical or clinical development(20). Therefore,
multiple targets and side effect possibility of flavonoids
as protein kinase inhibitors are required to be clarified in
further.
The evidence indicates that most of the plant-based
agents used in traditional Ayurvedic and Chinese medicine contain a variety of polyphenols, and do indeed suppress multiple pathways(4). Importantly, all of these signaling pathways have been found malfunctioning in cancer cells, resulting in cancer cell proliferation and inhibition of apoptosis. Therefore, it is important to design a
strategy that could simultaneously target multiple cellular
signaling pathways so that cancer cells could get killed
effectively. Therefore, targeting multiple signaling by
natural compounds has opened a new avenue for cancer
chemoprevention and therapy.
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